Steven D. Harr
2020 - Sana Biotechnology
In 2020, Steven D. Harr earned a total compensation of $6.8M as President, Chief Executive Officer, and Director at Sana Biotechnology.
Compensation breakdown
| Non-Equity Incentive Plan | $294,250 |
|---|---|
| Option Awards | $6,015,947 |
| Salary | $535,000 |
| Total | $6,845,197 |
Harr received $6M in option awards, accounting for 88% of the total pay in 2020.
Harr also received $294.3K in non-equity incentive plan and $535K in salary.
Rankings
In 2020, Steven D. Harr's compensation ranked 1,436th out of 13,090 executives tracked by ExecPay. In other words, Harr earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,436 out of 13,090 | 89th |
Division Manufacturing | 530 out of 5,620 | 91st |
Major group Chemicals And Allied Products | 189 out of 2,253 | 92nd |
Industry group Drugs | 160 out of 1,953 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 48 out of 411 | 88th |
Source: SEC filing on April 26, 2022.
News
Sana Biotechnology Former Executive Vice President and President, Research and Development Douglas Williams receives $3M in 2023
April 26, 2024
Sana Biotechnology General Counsel Bernard Cassidy receives $4M in 2022
April 28, 2023
Sana Biotechnology Chief Medical Officer Sunil Agarwal receives $1.9M in 2021
April 26, 2022